Medesis Pharma (France) Analysis
| ALMDP Stock | EUR 0.43 0.01 2.38% |
Medesis Pharma SA is overvalued with Real Value of 0.4 and Hype Value of 0.42. The main objective of Medesis Pharma stock analysis is to determine its intrinsic value, which is an estimate of what Medesis Pharma SA is worth, separate from its market price. There are two main types of Medesis Pharma's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Medesis Pharma's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Medesis Pharma's stock to identify patterns and trends that may indicate its future price movements.
The Medesis Pharma stock is traded in France on Euronext Paris, with the market opening at 09:00:00 and closing at 17:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in France. Medesis Pharma is usually not traded on Christmas Day, New Year 's Day, Easter Monday, International Workers ' Day, Victory in Europe Day. Medesis Stock trading window is adjusted to Europe/Paris timezone.
Medesis |
Medesis Stock Analysis Notes
About 17.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.74. Medesis Pharma SA had not issued any dividends in recent years. Medesis Pharma SA, a clinical development stage biopharmaceutical company, engages in the development of orally administered molecule drug candidates to address unmet medical needs. The company was founded in 2003 and is based in Montpellier, France. MEDESIS PHARMA is traded on Paris Stock Exchange in France. For more info on Medesis Pharma SA please contact JeanClaude Maurel at 33 4 67 03 03 96 or go to https://www.medesispharma.com.Medesis Pharma SA Investment Alerts
| Medesis Pharma SA generated a negative expected return over the last 90 days | |
| Medesis Pharma SA has high historical volatility and very poor performance | |
| Medesis Pharma SA has some characteristics of a very speculative penny stock | |
| The company reported the revenue of 95.73 K. Net Loss for the year was (2.65 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| About 17.0% of the company shares are held by company insiders |
Medesis Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 13.43 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Medesis Pharma's market, we take the total number of its shares issued and multiply it by Medesis Pharma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
As of the 25th of November, Medesis Pharma secures the Risk Adjusted Performance of (0.01), standard deviation of 10.93, and Mean Deviation of 6.73. Medesis Pharma SA technical analysis lets you operate historical price patterns with an objective to determine a pattern that forecasts the direction of the firm's future prices.Medesis Pharma SA Price Movement Analysis
The output start index for this execution was eleven with a total number of output elements of fifty. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Medesis Pharma middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Medesis Pharma SA. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Medesis Pharma Outstanding Bonds
Medesis Pharma issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Medesis Pharma SA uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Medesis bonds can be classified according to their maturity, which is the date when Medesis Pharma SA has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 4875 Corp BondUS55336VAG59 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| International Game Technology Corp BondUS460599AD57 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View |
Medesis Pharma Predictive Daily Indicators
Medesis Pharma intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Medesis Pharma stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Medesis Pharma Forecast Models
Medesis Pharma's time-series forecasting models are one of many Medesis Pharma's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Medesis Pharma's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Medesis Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Medesis Pharma prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Medesis shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Medesis Pharma. By using and applying Medesis Stock analysis, traders can create a robust methodology for identifying Medesis entry and exit points for their positions.
Medesis Pharma SA, a clinical development stage biopharmaceutical company, engages in the development of orally administered molecule drug candidates to address unmet medical needs. The company was founded in 2003 and is based in Montpellier, France. MEDESIS PHARMA is traded on Paris Stock Exchange in France.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Medesis Pharma to your portfolios without increasing risk or reducing expected return.Did you try this?
Run FinTech Suite Now
FinTech SuiteUse AI to screen and filter profitable investment opportunities |
| All Next | Launch Module |
Additional Tools for Medesis Stock Analysis
When running Medesis Pharma's price analysis, check to measure Medesis Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medesis Pharma is operating at the current time. Most of Medesis Pharma's value examination focuses on studying past and present price action to predict the probability of Medesis Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medesis Pharma's price. Additionally, you may evaluate how the addition of Medesis Pharma to your portfolios can decrease your overall portfolio volatility.